c-docker software biovia discovery studio visualizer 2019 (Accelrys)
90
Structured Review
Accelrys
c-docker software biovia discovery studio visualizer 2019
C Docker Software Biovia Discovery Studio Visualizer 2019, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c-docker+software+biovia+discovery+studio+visualizer+2019/c+docker+software+biovia+discovery+studio+visualizer+2019/pmc10989008-637-6-8
Average 90 stars, based on 1 article reviews
C Docker Software Biovia Discovery Studio Visualizer 2019, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c-docker+software+biovia+discovery+studio+visualizer+2019/c+docker+software+biovia+discovery+studio+visualizer+2019/pmc10989008-637-6-8
Average 90 stars, based on 1 article reviews
c-docker software biovia discovery studio visualizer 2019 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir Article Snippet: Docking experiments were performed using the Expressing:Article Title: BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir Article Snippet: Docking experiments were performed using the Western Blot:Article Title: BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir Article Snippet: Docking experiments were performed using the |